Used as an intermediate in the synthesis of pharmaceutical compounds, particularly in the development of kinase inhibitors for targeted cancer therapies. The di-tert-butyl ester groups and 4-fluoro-3,5-dimethylphenyl substituent enhance molecular stability, facilitate cell membrane permeability, and enable selective modifications in drug design, improving metabolic stability and binding affinity. Commonly employed in research settings for constructing complex hydrazine-based scaffolds in medicinal chemistry. Also utilized in agrochemical research for designing bioactive molecules with improved environmental stability. Additionally, it serves as a protecting reagent for hydrazine functionalities in multi-step syntheses, allowing regioselective reactions.